Uretron D/s Tablet
Product Images NDC 12539-144

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Uretron D/s (NDC 12539-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Uretron (Uretron Ds 100ct Label)

Label for Uretron D/S oral tablets containing methenamine 81.6 mg, sodium phosphate monobasic 40.8 mg, phenyl salicylate 36.2 mg, methylene blue 10.8 mg, and hyoscyamine sulfate 0.12 mg. The package contains 100 tablets, manufactured for A.G. Marin Pharmaceuticals. Includes pharmacist and patient notes about storage, urine discoloration, and child-resistant packaging. NDC 12539-144-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.